- Drug Discovery & Preclinical
- Monoclonal Antibodies
- Antibody-Drug Conjugates
- Vaccines (Prophylactic & Therapeutic)
- Cell & Gene Therapies (CGT)
- Allergy & Hypersensitivity
- Biomarker
- High-Dimensional Single-Cell Analysis by Flow Cytometry
- High-Throughput Cytokine & Chemokine Profiling by Multiplexing
- Biomarkers via Advanced IHC & Spatial Imaging
- Rare Cellular Functional Biomarkers by ELISPOT
- Real-Time Kinetic Biomarkers by IncuCyte S3
- Genomic Biomarker Analysis by qPCR & Droplet Digital PCR
- Seahorse XF: Immunometabolism & Bioenergetics
- MALDI Biotyper: Rapid Microbial & Proteomic Profiling
- Sapidyne KinExA
- Robust Protein Quantification by ELISA
- Advanced LNP Formulation & Screening – Unchained Labs Sunshine
- Translational & Clinical Research
- Immunogenicity Risk Assessment & Immunotoxicology
- Regulated Bioanalysis: PK, PD & Soluble Biomarkers
- Histopathology & Spatial Biology
- Advanced Flow Cytometry & Cellular Immunology
- Molecular Bioanalysis & Genomic Profiling
- Functional Potency & Ex Vivo Translational Models
- Central Laboratory & Clinical Trial Sample Management
- Dermo-Cosmetics & FMCG
- Nutraceuticals & Wellness
- Biorepository
Vaccine Immunogenicity & Immune Response Analysis
Modern vaccine development extends beyond neutralizing antibody titers. Successful vaccines require comprehensive evaluation of cellular immunity, humoral immunity, immune durability, and safety to demonstrate long-term protective efficacy.
ImmunitasBio provides advanced vaccine immunogenicity testing and immune response analysis for preclinical and clinical vaccine development. Our integrated bioanalytical platforms generate high-resolution data to evaluate immune responses, identify correlates of protection, and accelerate next-generation vaccine development.
Core Capabilities :
- Cellular Immunity & Deep Immune Phenotyping
- Humoral Immunity & Antibody Durability Assessment
- Vaccine Safety, Immune Polarization & Cytokine Profiling
From discovery through clinical development, ImmunitasBio delivers precise, publication-ready immunology data that drives confident vaccine development decisions.